Transcriptomics

Dataset Information

0

Ginsenoside Rh2 Attenuates Post-Myocardial Infarction Heart Failure by Modulating the TGF-β/Smad2 Signaling Pathway


ABSTRACT: Background: Myocardial fibrosis and oxidative stress are key drivers of post-myocardial infarction heart failure (post-MI HF). Ginsenoside Rh2 (GRh2) has shown cardioprotective potential, but its role in post-MI HF and the underlying mechanism remain unclear. The current study aimed to investigate the therapeutic effect of GRh2 on post-MI HF and to validate its regulatory mechanism using murine, cellular, and cardiac organoid models. Methods: In vivo, Cardiac function and myocardial fibrosis were evaluated. Transcriptome analysis was performed to identify enriched signaling pathways. In vitro, H9C2 cardiomyocytes and cardiac organoids were subjected to oxygen-glucose deprivation (OGD). Cardiac injury indicators, fibrotic and oxidative stress markers, and proteins associated with the TGF-β/Smad2 pathway were measured via enzyme-linked immunosorbent assay (ELISA) and Western blotting. Results: In vivo, GRh2 treatment markedly improved cardiac function and reduced myocardial fibrosis in mice with post-MI heart failure. Transcriptomic analysis revealed that the TGF-β signaling pathway was substantially enriched. In vitro, GRh2 treatment significantly improved cell viability and reduced oxidative stress and fibrosis in OGD-exposed H9C2 cardiomyocytes and cardiac organoids. These protective effects were strongly associated with the suppression of the TGF-β/Smad2 signaling pathway. Conclusions: Ginsenoside Rh2 inhibits the TGF‑β/Smad2 signaling pathway to ameliorate cardiac dysfunction in post-MI heart failure, suggesting its potential as a therapeutic candidate.

ORGANISM(S): Mus musculus

PROVIDER: GSE348247 | GEO | 2026/09/30

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
GSE348247_gene_expression.txt.gz Txt
Items per page:
1 - 2 of 2

Similar Datasets

2025-12-22 | PXD072325 |
2024-07-01 | GSE240310 | GEO
2022-12-12 | GSE183932 | GEO
2022-12-12 | GSE185265 | GEO
2026-03-02 | GSE320263 | GEO
2026-06-01 | GSE319401 | GEO
2026-03-03 | MTBLS13965 | MetaboLights
2025-01-18 | PXD055651 | Pride
2026-03-25 | E-MTAB-16586 | biostudies-arrayexpress
2023-11-14 | GSE247062 | GEO